Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MLTX
#2020
MoonLake Immunotherapeutics Class A Ordinary Shares
17.510
0
-0.68%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
-0.68%
Mudança mensal
+7.49%
Mudança em 6 meses
+83.16%
Mudança anual
+83.16%
Fechamento anterior
17.630
0
Open
17.510
0
Bid
Ask
Low
17.510
0
High
17.510
0
Volume
76
Mercados
Ações
Cuidados de saúde
MLTX
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
11.93 M
11.93 M
39.15 M
62.87 M
63.28 M
71.73 M
—
Valuation ratios
Enterprise value
—
—
1.72 B
10.98 B
10.22 B
2.5 B
19.59 B
Price to earnings ratio
—
—
-6.49
-81.58
-28.65
-3.73
-39.86
Price to sales ratio
—
—
995.06
19.31 K
-80.7 K
1 418.42
3 765.23
Price to cash flow ratio
—
—
-5.79
-68.38
-29.2
4.33
-27.34
Price to book ratio
—
—
6.62
5.9
7.62
2.79
6.17
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
—
-0.04
-0.65
-0.07
-0.25
0.54
0.51
Return on equity %
—
0.64
-0.73
-0.07
-0.26
0.75
0.7
Return on invested capital %
—
—
-427.73
-1 699.61
-2 635.87
2 828.78
2 975.79
Gross margin %
—
—
100
100
100
100
400
Operating margin %
—
—
-20 K
-35.73 K
339.19 K
40.87 K
97.97 K
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
-15.36 K
-23.77 K
281.93 K
37.95 K
77.78 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
12.93
0.21
9.98
51.59
21.11
9.27
55.53
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
0
0
-0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0
0
—
—
—
0.17
0.65
Long term debt to total equity ratio
0.01
0
—
—
—
0.24
0.89
Per share metrics
Operating cash flow per share
—
-0
-1.9
-0.87
-1.85
3.04
3.08
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
0
2.46
10.4
7.13
6.11
26.43
Net current asset value per share
—
0
2.61
10.47
7.54
6.54
28.23
Tangible book value per share
—
-0.02
1.67
10.09
7.11
4.72
21.32
Working capital per share
—
-0.01
2.34
10.26
7.19
5.84
25.95
Book value per share
—
-0.02
1.67
10.09
7.11
4.72
21.32
Notícias
MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal (NASDAQ:MLTX)
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day - Slideshow (NASDAQ:MLTX) 2026-02-23
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day Transcript
Ações da MoonLake disparam com dados positivos do estudo em axSpA
MoonLake stock surges on positive axSpA trial data
Ações da MoonLake disparam 63% após análise de preço-justo do InvestingPro
MoonLake stock surges 63% after InvestingPro Fair Value call
MoonLake apresenta dados positivos de fase 2 em espondiloartrite axial
MoonLake reports positive phase 2 axial spondyloarthritis data
ImageneBio appoints Dr. Porter-Brown as Chief Medical Officer
BTIG reitera recomendação de compra para ações da Moonlake Immunotherapeutics antes de novos dados
BTIG reiterates Buy rating on Moonlake Immunotherapeutics stock ahead of data